In a xenograft tumor model, we observed a trend of reduction of the CyclinD1 and Pcna gene expression levels in HT-29 cells treated with P-selectin KO platelets compared to HT-29 cells treated with control platelets (Supplementary Figure S2). Here, CCND1 is linked to neoplasm.